Highlights: -Immunotherapy could transform systemic power of locoregional IO treatments -Randomised data favour Y-90 therapy over conventional chemoembolization in patients with unresectable hepatocellular carcinoma -Kamran Ahrar: Chemoembolization -Luigi Solbiati: Fusion imaging -Profile: Constantinos Sofocleous
[pdfviewer width=”100%” height=”940px” beta=”true”]http://interventionalnews.com/wp-content/uploads/sites/13/2016/07/62-Interventional-News_low-res.pdf[/pdfviewer]
